Gain Therapeutics (GANX) Long-Term Debt Issuances (2020)
Gain Therapeutics' Long-Term Debt Issuances came in at $30,396 for Q4 2020, down 92.8% from the prior quarter.
Powered by 
Analysis
Gain Therapeutics (GANX) Long-Term Debt Issuances (2020) Analysis & Trends
For FY2020, Gain Therapeutics' Long-Term Debt Issuances was $738,282.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Issuance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,171.89 Bn | 1,140.48 Bn | 19.71 Bn | 8.94 Bn |
| 2 | Johnson & Johnson | 646.13 Bn | 566.00 Bn | 17.30 Bn | - |
| 3 | AbbVie | 503.44 Bn | 476.55 Bn | 12.70 Bn | - |
| 4 | Merck | 364.55 Bn | 318.93 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 303.38 Bn | 267.37 Bn | 11.24 Bn | 1.98 Bn |
| 6 | Astrazeneca | 268.82 Bn | 242.51 Bn | 12.86 Bn | - |
| 7 | Amgen | 242.30 Bn | 197.70 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.37 Bn | 168.56 Bn | 6.22 Bn | - |
| 9 | Pfizer | 172.11 Bn | 118.76 Bn | 10.94 Bn | - |
| 10 | Gain Therapeutics | 55.32 Mn | -3.97 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 30,396.00 |
| Sep 30, 2020 | 423,288.00 |
| Mar 31, 2020 | 284,598.00 |
API Access
Gain Therapeutics Long-Term Debt Issuances API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=GANX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-issuances", "ticker": "GANX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=GANX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();